These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8999872)
21. Binding of src-like kinases to the beta-subunit of the interleukin-3 receptor. Burton EA; Hunter S; Wu SC; Anderson SM J Biol Chem; 1997 Jun; 272(26):16189-95. PubMed ID: 9195918 [TBL] [Abstract][Full Text] [Related]
22. Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae. Murphy SM; Bergman M; Morgan DO Mol Cell Biol; 1993 Sep; 13(9):5290-300. PubMed ID: 7689149 [TBL] [Abstract][Full Text] [Related]
23. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner. Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623 [TBL] [Abstract][Full Text] [Related]
24. Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibition. Dokmanovic M; Wu Y; Shen Y; Chen J; Hirsch DS; Wu WJ Cancer Biol Ther; 2014 Aug; 15(8):1029-41. PubMed ID: 24835103 [TBL] [Abstract][Full Text] [Related]
25. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets. Hirao A; Hamaguchi I; Suda T; Yamaguchi N EMBO J; 1997 May; 16(9):2342-51. PubMed ID: 9171348 [TBL] [Abstract][Full Text] [Related]
26. Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK. Mikkola ET; Bergman M FEBS Lett; 2003 Jun; 544(1-3):11-4. PubMed ID: 12782282 [TBL] [Abstract][Full Text] [Related]
27. Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line. Davidson D; Chow LM; Veillette A J Biol Chem; 1997 Jan; 272(2):1355-62. PubMed ID: 8995444 [TBL] [Abstract][Full Text] [Related]
28. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes. Summy JM; Guappone AC; Sudol M; Flynn DC Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading. Hirao A; Huang XL; Suda T; Yamaguchi N J Biol Chem; 1998 Apr; 273(16):10004-10. PubMed ID: 9545346 [TBL] [Abstract][Full Text] [Related]
30. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. Luttrell LM; Della Rocca GJ; van Biesen T; Luttrell DK; Lefkowitz RJ J Biol Chem; 1997 Feb; 272(7):4637-44. PubMed ID: 9020193 [TBL] [Abstract][Full Text] [Related]
31. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice. Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283 [TBL] [Abstract][Full Text] [Related]
32. Domain interactions in protein tyrosine kinase Csk. Sondhi D; Cole PA Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171 [TBL] [Abstract][Full Text] [Related]
33. Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors. Kim SO; Avraham S; Jiang S; Zagozdzon R; Fu Y; Avraham HK Cancer; 2004 Sep; 101(5):1018-27. PubMed ID: 15329911 [TBL] [Abstract][Full Text] [Related]
34. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity. Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335 [TBL] [Abstract][Full Text] [Related]
35. Csk is constitutively associated with a 60-kDa tyrosine-phosphorylated protein in human T cells. Catipović B; Schneck JP; Brummet ME; Marsh DG; Rafnar T J Biol Chem; 1996 Apr; 271(16):9698-703. PubMed ID: 8621646 [TBL] [Abstract][Full Text] [Related]
36. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase. Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606 [TBL] [Abstract][Full Text] [Related]
37. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Chong YP; Ia KK; Mulhern TD; Cheng HC Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159 [TBL] [Abstract][Full Text] [Related]
38. CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion. Fu Y; Zagozdzon R; Avraham R; Avraham HK Int J Oncol; 2006 Dec; 29(6):1453-8. PubMed ID: 17088984 [TBL] [Abstract][Full Text] [Related]
39. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Zrihan-Licht S; Fu Y; Settleman J; Schinkmann K; Shaw L; Keydar I; Avraham S; Avraham H Oncogene; 2000 Mar; 19(10):1318-28. PubMed ID: 10713673 [TBL] [Abstract][Full Text] [Related]
40. Association of p59(fyn) with the T lymphocyte costimulatory receptor CD2. Binding of the Fyn Src homology (SH) 3 domain is regulated by the Fyn SH2 domain. Lin H; Hutchcroft JE; Andoniou CE; Kamoun M; Band H; Bierer BE J Biol Chem; 1998 Jul; 273(31):19914-21. PubMed ID: 9677430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]